The corticobasal syndrome–Alzheimer’s disease conundrum
暂无分享,去创建一个
[1] Chris Frost,et al. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. , 2005, Cerebral cortex.
[2] Hitoshi Takahashi,et al. Alzheimer's disease: Report of two autopsy cases with a clinical diagnosis of corticobasal degeneration , 2010, Neuropathology : official journal of the Japanese Society of Neuropathology.
[3] T. Mizutani,et al. [Autopsy case of atypical type of alzheimer's disease clinically diagnosed as corticobasal degeneration]. , 2007, Rinsho shinkeigaku = Clinical neurology.
[4] J. O'Brien,et al. PET imaging of brain amyloid in dementia: a review , 2011, International journal of geriatric psychiatry.
[5] Joseph James Duffy,et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.
[6] A. Lang,et al. Motor neuron disease‐inclusion dementia presenting as cortical‐basal ganglionic degeneration , 1999, Movement disorders : official journal of the Movement Disorder Society.
[7] J. Kramer,et al. Alzheimer's Disease and Its Focal Variants , 2000, Seminars in neurology.
[8] J. Jankovic,et al. and J Jankovic The alien hand and related signs , 2022 .
[9] H C Hendrie,et al. Epidemiology of dementia and Alzheimer's disease. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[10] A. Sirigu,et al. The neuropsychological pattern of corticobasal degeneration , 1995, Neurology.
[11] M N Rossor,et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype , 2001, Neurology.
[12] C. Marsden,et al. Alien hand sign in association with Alzheimer's histopathology. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[13] P. Hof,et al. Motor Cortex Involvement in Presenile Dementia: Report of a Case , 1992, Journal of geriatric psychiatry and neurology.
[14] E. Green,et al. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain , 2002, Neuroscience Letters.
[15] D. Radice,et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.
[16] J. Hodges,et al. Neuropathological background of phenotypical variability in frontotemporal dementia , 2011, Acta Neuropathologica.
[17] Hilkka Soininen,et al. J-ADNI and selection of cognition measures , 2010, Alzheimer's & Dementia.
[18] William T. Hu,et al. Anatomical differences between CBS‐corticobasal degeneration and CBS‐Alzheimer's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[19] T. Mizutani,et al. Imaging of corticobasal degeneration syndrome , 2007, Neuroradiology.
[20] A Klug,et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Linda S Hynan,et al. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] H. Mizusawa,et al. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET , 2001, Nuclear medicine communications.
[23] J. Hardy,et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. , 2006, Brain : a journal of neurology.
[24] M. Doran,et al. Language function and dysfunction in corticobasal degeneration , 2004, Neurology.
[25] H J Testa,et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[26] K. Kaida,et al. Alzheimer's disease with asymmetric parietal lobe atrophy: A case report , 1998, Journal of the Neurological Sciences.
[27] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[28] Clifford R Jack,et al. Rates of cerebral atrophy differ in different degenerative pathologies. , 2006, Brain : a journal of neurology.
[29] B. Boeve. Links Between Frontotemporal Lobar Degeneration, Corticobasal Degeneration, Progressive Supranuclear Palsy, and Amyotrophic Lateral Sclerosis , 2007, Alzheimer disease and associated disorders.
[30] Nick C Fox,et al. Neurofilament inclusion body disease: a new proteinopathy? , 2003, Brain : a journal of neurology.
[31] D. Horoupian,et al. Alzheimer’s disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration , 1999, Acta Neuropathologica.
[32] B. Choe,et al. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis , 2005, Neuroscience Letters.
[33] M. Weiner,et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. , 2010, Brain : a journal of neurology.
[34] A Hofman,et al. Risk Factors for Alzheimer's Disease: Overview of the EURODEM Collaborative Re-Analysis of Case-Control Studies , 1991 .
[35] Gwenn S. Smith,et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. , 1991, Radiology.
[36] Irene Litvan,et al. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.
[37] M. Doran,et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration , 2003, Journal of the Neurological Sciences.
[38] C. Jack,et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. , 2004, Archives of neurology.
[39] K Patterson,et al. Focal cortical presentations of Alzheimer's disease. , 2007, Brain : a journal of neurology.
[40] D. Gottlieb,et al. Mirror movements in the alien hand syndrome. Case report. , 1992, American journal of physical medicine & rehabilitation.
[41] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[42] G. Schellenberg,et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. , 2010, Archives of neurology.
[43] C. Jack,et al. Imaging correlates of pathology in corticobasal syndrome , 2010, Neurology.
[44] C. Jack,et al. Symmetric corticobasal degeneration (S-CBD). , 2010, Parkinsonism & related disorders.
[45] C. Jack,et al. Voxel-based morphometry in autopsy proven PSP and CBD , 2008, Neurobiology of Aging.
[46] H. Braak,et al. Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.
[47] B. Borroni,et al. CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[48] J. Grafman,et al. Alzheimer's disease presenting as corticobasal syndrome , 2006, Movement disorders : official journal of the Movement Disorder Society.
[49] E. Richardson,et al. Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.
[50] C. Jack,et al. Prominent phenotypic variability associated with mutations in Progranulin , 2009, Neurobiology of Aging.
[51] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[52] A. Lleó,et al. Asymmetric myoclonic parietal syndrome in a patient with Alzheimer's disease mimicking corticobasal degeneration. , 2002, Neurología.
[53] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[54] G. Vega,et al. Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease , 1999, Biological Psychiatry.
[55] K. Dujardin,et al. Neural and cognitive bases of upper limb apraxia in corticobasal degeneration , 2001, Neurology.
[56] J. Cummings. Biomarkers in Alzheimer's Disease—Perspectives for the Future , 2010 .
[57] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[58] R. Katzman.,et al. Biopsy‐proved Alzheimer disease presenting as a right parietal lobe syndrome , 1982, Annals of neurology.
[59] C. Jack,et al. Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.
[60] J. Hodges,et al. Is the pathology of corticobasal syndrome predictable in life? , 2009, Movement disorders : official journal of the Movement Disorder Society.
[61] J. P. Brandel,et al. Accuracy of the Clinical Diagnosis of Corticobasal Degeneration , 1997, Neurology.
[62] A. Lees,et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. , 2010, Brain : a journal of neurology.
[63] A. Fleisher,et al. Altered default mode network connectivity in alzheimer's disease—A resting functional MRI and bayesian network study , 2011, Human brain mapping.
[64] D. Dickson,et al. Corticobasal syndrome with Alzheimer's disease pathology , 2009, Movement disorders : official journal of the Movement Disorder Society.
[65] R. S. Williams,et al. Alzheimer's disease presenting as slowly progressive aphasia. , 1984, Rhode Island medical journal.
[66] W. Jagust,et al. Focal Alzheimer's disease , 1990, Neurology.
[67] Jennifer L. Whitwell,et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. , 2006, Brain : a journal of neurology.
[68] M. Poncet,et al. [Progressive severity of left unilateral apraxia in 2 cases of Alzheimer disease]. , 1995, Revue neurologique.
[69] J. Trojanowski,et al. Clinicopathological correlations in corticobasal degeneration , 2011, Annals of neurology.
[70] K. Blennow,et al. CSF markers for incipient Alzheimer's disease , 2003, The Lancet Neurology.
[71] J. Molinuevo,et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease , 2011, Neurology.
[72] E. Tolosa,et al. Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting , 2005, Movement disorders : official journal of the Movement Disorder Society.
[73] Clifford R Jack,et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. , 2007, Brain : a journal of neurology.
[74] A. Lang,et al. Dementia as the most common presentation of cortical-basal ganglionic degeneration , 1999, Neurology.
[75] M. Mendez,et al. Cognitive Differences between Early- and Late-Onset Alzheimer's Disease , 2007, American journal of Alzheimer's disease and other dementias.
[76] P. S. Mathuranath,et al. Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA) , 2005, Neurocase.
[77] D. Eberhard,et al. Alzheimer's disease in a case of cortical basal ganglionic degeneration with severe dementia. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[78] Katy A. Cross,et al. Patterns of neuropsychological impairment in frontotemporal dementia , 2007, Neurology.
[79] R. Petersen,et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.
[80] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[81] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[82] H. Soininen,et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. , 2009, Archives of neurology.
[83] K. Leenders,et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases , 2010, Movement disorders : official journal of the Movement Disorder Society.